世界のデクスランソプラゾールAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Dexlansoprazole API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1089 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はデクスランソプラゾールAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。デクスランソプラゾールAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（デクスランソプラゾールカプセル、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・デクスランソプラゾールAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・デクスランソプラゾールAPIの種類別市場規模：純度≥98％、純度<98％ ・デクスランソプラゾールAPIの用途別市場規模：デクスランソプラゾールカプセル、その他 ・北米のデクスランソプラゾールAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのデクスランソプラゾールAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのデクスランソプラゾールAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のデクスランソプラゾールAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのデクスランソプラゾールAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Piramal Enterprises Limited、Metrochem API Private Limited、Zhejiang Hengkang Pharmaceutical、Lupin Ltd、Dipharma、Optimus Pharma P Limited、Orchid Chemicals & Pharmaceuticals ・デクスランソプラゾールAPIのバリューチェーン・販売チャネル分析 ・デクスランソプラゾールAPIの世界市場動向

Dexlansoprazole is used to heal and maintain healing of erosive esophagitis and to treat heartburn associated with gastroesophageal reflux disease (GERD). It lasts longer than lansoprazole, to which it is chemically related, and needs to be taken less often. There is no good evidence that it works better than other PPIs.

Market Analysis and Insights: Global Dexlansoprazole API Market
The global Dexlansoprazole API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Dexlansoprazole API Scope and Segment
Dexlansoprazole API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dexlansoprazole API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Dexlansoprazole Capsules Others By Company Piramal Enterprises Limited Metrochem API Private Limited Zhejiang Hengkang Pharmaceutical Lupin Ltd Dipharma Optimus Pharma P Limited Orchid Chemicals & Pharmaceuticals Production by Region Europe China China Taiwan India Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Dexlansoprazole API Product Introduction
1.2 Market by Type
1.2.1 Global Dexlansoprazole API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Dexlansoprazole API Market Size Growth Rate by Application 1.3.2 Dexlansoprazole Capsules 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Dexlansoprazole API Production 2.1 Global Dexlansoprazole API Production Capacity (2016-2027) 2.2 Global Dexlansoprazole API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Dexlansoprazole API Production by Region 2.3.1 Global Dexlansoprazole API Historic Production by Region (2016-2021) 2.3.2 Global Dexlansoprazole API Forecasted Production by Region (2022-2027) 2.4 Europe 2.5 China 2.6 China Taiwan 2.7 India 3 Global Dexlansoprazole API Sales in Volume & Value Estimates and Forecasts 3.1 Global Dexlansoprazole API Sales Estimates and Forecasts 2016-2027 3.2 Global Dexlansoprazole API Revenue Estimates and Forecasts 2016-2027 3.3 Global Dexlansoprazole API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Dexlansoprazole API Regions by Sales 3.4.1 Global Top Dexlansoprazole API Regions by Sales (2016-2021) 3.4.2 Global Top Dexlansoprazole API Regions by Sales (2022-2027) 3.5 Global Top Dexlansoprazole API Regions by Revenue 3.5.1 Global Top Dexlansoprazole API Regions by Revenue (2016-2021) 3.5.2 Global Top Dexlansoprazole API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Dexlansoprazole API Production Capacity by Manufacturers 4.2 Global Dexlansoprazole API Sales by Manufacturers 4.2.1 Global Top Dexlansoprazole API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Dexlansoprazole API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Dexlansoprazole API Sales in 2020 4.3 Global Dexlansoprazole API Revenue by Manufacturers 4.3.1 Global Top Dexlansoprazole API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Dexlansoprazole API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Dexlansoprazole API Revenue in 2020 4.4 Global Dexlansoprazole API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Dexlansoprazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Dexlansoprazole API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Dexlansoprazole API Sales by Type 5.1.1 Global Dexlansoprazole API Historical Sales by Type (2016-2021) 5.1.2 Global Dexlansoprazole API Forecasted Sales by Type (2022-2027) 5.1.3 Global Dexlansoprazole API Sales Market Share by Type (2016-2027) 5.2 Global Dexlansoprazole API Revenue by Type 5.2.1 Global Dexlansoprazole API Historical Revenue by Type (2016-2021) 5.2.2 Global Dexlansoprazole API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Dexlansoprazole API Revenue Market Share by Type (2016-2027) 5.3 Global Dexlansoprazole API Price by Type 5.3.1 Global Dexlansoprazole API Price by Type (2016-2021) 5.3.2 Global Dexlansoprazole API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Dexlansoprazole API Sales by Application 6.1.1 Global Dexlansoprazole API Historical Sales by Application (2016-2021) 6.1.2 Global Dexlansoprazole API Forecasted Sales by Application (2022-2027) 6.1.3 Global Dexlansoprazole API Sales Market Share by Application (2016-2027) 6.2 Global Dexlansoprazole API Revenue by Application 6.2.1 Global Dexlansoprazole API Historical Revenue by Application (2016-2021) 6.2.2 Global Dexlansoprazole API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Dexlansoprazole API Revenue Market Share by Application (2016-2027) 6.3 Global Dexlansoprazole API Price by Application 6.3.1 Global Dexlansoprazole API Price by Application (2016-2021) 6.3.2 Global Dexlansoprazole API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Dexlansoprazole API Market Size by Type 7.1.1 North America Dexlansoprazole API Sales by Type (2016-2027) 7.1.2 North America Dexlansoprazole API Revenue by Type (2016-2027) 7.2 North America Dexlansoprazole API Market Size by Application 7.2.1 North America Dexlansoprazole API Sales by Application (2016-2027) 7.2.2 North America Dexlansoprazole API Revenue by Application (2016-2027) 7.3 North America Dexlansoprazole API Sales by Country 7.3.1 North America Dexlansoprazole API Sales by Country (2016-2027) 7.3.2 North America Dexlansoprazole API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Dexlansoprazole API Market Size by Type 8.1.1 Europe Dexlansoprazole API Sales by Type (2016-2027) 8.1.2 Europe Dexlansoprazole API Revenue by Type (2016-2027) 8.2 Europe Dexlansoprazole API Market Size by Application 8.2.1 Europe Dexlansoprazole API Sales by Application (2016-2027) 8.2.2 Europe Dexlansoprazole API Revenue by Application (2016-2027) 8.3 Europe Dexlansoprazole API Sales by Country 8.3.1 Europe Dexlansoprazole API Sales by Country (2016-2027) 8.3.2 Europe Dexlansoprazole API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Dexlansoprazole API Market Size by Type 9.1.1 Asia Pacific Dexlansoprazole API Sales by Type (2016-2027) 9.1.2 Asia Pacific Dexlansoprazole API Revenue by Type (2016-2027) 9.2 Asia Pacific Dexlansoprazole API Market Size by Application 9.2.1 Asia Pacific Dexlansoprazole API Sales by Application (2016-2027) 9.2.2 Asia Pacific Dexlansoprazole API Revenue by Application (2016-2027) 9.3 Asia Pacific Dexlansoprazole API Sales by Region 9.3.1 Asia Pacific Dexlansoprazole API Sales by Region (2016-2027) 9.3.2 Asia Pacific Dexlansoprazole API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Dexlansoprazole API Market Size by Type 10.1.1 Latin America Dexlansoprazole API Sales by Type (2016-2027) 10.1.2 Latin America Dexlansoprazole API Revenue by Type (2016-2027) 10.2 Latin America Dexlansoprazole API Market Size by Application 10.2.1 Latin America Dexlansoprazole API Sales by Application (2016-2027) 10.2.2 Latin America Dexlansoprazole API Revenue by Application (2016-2027) 10.3 Latin America Dexlansoprazole API Sales by Country 10.3.1 Latin America Dexlansoprazole API Sales by Country (2016-2027) 10.3.2 Latin America Dexlansoprazole API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Dexlansoprazole API Market Size by Type 11.1.1 Middle East and Africa Dexlansoprazole API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Dexlansoprazole API Revenue by Type (2016-2027) 11.2 Middle East and Africa Dexlansoprazole API Market Size by Application 11.2.1 Middle East and Africa Dexlansoprazole API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Dexlansoprazole API Revenue by Application (2016-2027) 11.3 Middle East and Africa Dexlansoprazole API Sales by Country 11.3.1 Middle East and Africa Dexlansoprazole API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Dexlansoprazole API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Piramal Enterprises Limited 12.1.1 Piramal Enterprises Limited Corporation Information 12.1.2 Piramal Enterprises Limited Overview 12.1.3 Piramal Enterprises Limited Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Piramal Enterprises Limited Dexlansoprazole API Product Description 12.1.5 Piramal Enterprises Limited Recent Developments 12.2 Metrochem API Private Limited 12.2.1 Metrochem API Private Limited Corporation Information 12.2.2 Metrochem API Private Limited Overview 12.2.3 Metrochem API Private Limited Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Metrochem API Private Limited Dexlansoprazole API Product Description 12.2.5 Metrochem API Private Limited Recent Developments 12.3 Zhejiang Hengkang Pharmaceutical 12.3.1 Zhejiang Hengkang Pharmaceutical Corporation Information 12.3.2 Zhejiang Hengkang Pharmaceutical Overview 12.3.3 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Product Description 12.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments 12.4 Lupin Ltd 12.4.1 Lupin Ltd Corporation Information 12.4.2 Lupin Ltd Overview 12.4.3 Lupin Ltd Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Lupin Ltd Dexlansoprazole API Product Description 12.4.5 Lupin Ltd Recent Developments 12.5 Dipharma 12.5.1 Dipharma Corporation Information 12.5.2 Dipharma Overview 12.5.3 Dipharma Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Dipharma Dexlansoprazole API Product Description 12.5.5 Dipharma Recent Developments 12.6 Optimus Pharma P Limited 12.6.1 Optimus Pharma P Limited Corporation Information 12.6.2 Optimus Pharma P Limited Overview 12.6.3 Optimus Pharma P Limited Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Optimus Pharma P Limited Dexlansoprazole API Product Description 12.6.5 Optimus Pharma P Limited Recent Developments 12.7 Orchid Chemicals & Pharmaceuticals 12.7.1 Orchid Chemicals & Pharmaceuticals Corporation Information 12.7.2 Orchid Chemicals & Pharmaceuticals Overview 12.7.3 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Product Description 12.7.5 Orchid Chemicals & Pharmaceuticals Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Dexlansoprazole API Industry Chain Analysis 13.2 Dexlansoprazole API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Dexlansoprazole API Production Mode & Process 13.4 Dexlansoprazole API Sales and Marketing 13.4.1 Dexlansoprazole API Sales Channels 13.4.2 Dexlansoprazole API Distributors 13.5 Dexlansoprazole API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Dexlansoprazole API Industry Trends 14.2 Dexlansoprazole API Market Drivers 14.3 Dexlansoprazole API Market Challenges 14.4 Dexlansoprazole API Market Restraints 15 Key Finding in The Global Dexlansoprazole API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Dexlansoprazole API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Dexlansoprazole API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Dexlansoprazole API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Dexlansoprazole API Production by Region (2016-2021) & (Ton)
Table 7. Global Dexlansoprazole API Production Market Share by Region (2016-2021)
Table 8. Global Dexlansoprazole API Production by Region (2022-2027) & (Ton)
Table 9. Global Dexlansoprazole API Production Market Share by Region (2022-2027)
Table 10. Global Dexlansoprazole API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Dexlansoprazole API Sales by Region (2016-2021) & (Ton)
Table 12. Global Dexlansoprazole API Sales Market Share by Region (2016-2021)
Table 13. Global Dexlansoprazole API Sales by Region (2022-2027) & (Ton)
Table 14. Global Dexlansoprazole API Sales Market Share by Region (2022-2027)
Table 15. Global Dexlansoprazole API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Dexlansoprazole API Revenue Market Share by Region (2016-2021)
Table 17. Global Dexlansoprazole API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Dexlansoprazole API Revenue Market Share by Region (2022-2027)
Table 19. Global Dexlansoprazole API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Dexlansoprazole API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Dexlansoprazole API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Dexlansoprazole API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Dexlansoprazole API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Dexlansoprazole API Sales Share by Manufacturers (2016-2021)
Table 25. Global Dexlansoprazole API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Dexlansoprazole API Revenue Share by Manufacturers (2016-2021)
Table 27. Dexlansoprazole API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Dexlansoprazole API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Dexlansoprazole API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dexlansoprazole API as of 2020)
Table 30. Dexlansoprazole API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Dexlansoprazole API Product Offered
Table 32. Date of Manufacturers Enter into Dexlansoprazole API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Dexlansoprazole API Sales by Type (2016-2021) & (Ton)
Table 35. Global Dexlansoprazole API Sales by Type (2022-2027) & (Ton)
Table 36. Global Dexlansoprazole API Sales Share by Type (2016-2021)
Table 37. Global Dexlansoprazole API Sales Share by Type (2022-2027)
Table 38. Global Dexlansoprazole API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Dexlansoprazole API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Dexlansoprazole API Revenue Share by Type (2016-2021)
Table 41. Global Dexlansoprazole API Revenue Share by Type (2022-2027)
Table 42. Dexlansoprazole API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Dexlansoprazole API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Dexlansoprazole API Sales by Application (2016-2021) & (Ton)
Table 45. Global Dexlansoprazole API Sales by Application (2022-2027) & (Ton)
Table 46. Global Dexlansoprazole API Sales Share by Application (2016-2021)
Table 47. Global Dexlansoprazole API Sales Share by Application (2022-2027)
Table 48. Global Dexlansoprazole API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Dexlansoprazole API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Dexlansoprazole API Revenue Share by Application (2016-2021)
Table 51. Global Dexlansoprazole API Revenue Share by Application (2022-2027)
Table 52. Dexlansoprazole API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Dexlansoprazole API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Dexlansoprazole API Sales by Type (2016-2021) & (Ton)
Table 55. North America Dexlansoprazole API Sales by Type (2022-2027) & (Ton)
Table 56. North America Dexlansoprazole API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Dexlansoprazole API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Dexlansoprazole API Sales by Application (2016-2021) & (Ton)
Table 59. North America Dexlansoprazole API Sales by Application (2022-2027) & (Ton)
Table 60. North America Dexlansoprazole API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Dexlansoprazole API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Dexlansoprazole API Sales by Country (2016-2021) & (Ton)
Table 63. North America Dexlansoprazole API Sales by Country (2022-2027) & (Ton)
Table 64. North America Dexlansoprazole API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Dexlansoprazole API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Dexlansoprazole API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Dexlansoprazole API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Dexlansoprazole API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Dexlansoprazole API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Dexlansoprazole API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Dexlansoprazole API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Dexlansoprazole API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Dexlansoprazole API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Dexlansoprazole API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Dexlansoprazole API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Dexlansoprazole API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Dexlansoprazole API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Dexlansoprazole API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Dexlansoprazole API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Dexlansoprazole API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Dexlansoprazole API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Dexlansoprazole API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Dexlansoprazole API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Dexlansoprazole API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Dexlansoprazole API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Dexlansoprazole API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Dexlansoprazole API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Dexlansoprazole API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Dexlansoprazole API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Dexlansoprazole API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Dexlansoprazole API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Dexlansoprazole API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Dexlansoprazole API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Dexlansoprazole API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Dexlansoprazole API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Dexlansoprazole API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Dexlansoprazole API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Dexlansoprazole API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Dexlansoprazole API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Dexlansoprazole API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Dexlansoprazole API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Dexlansoprazole API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Dexlansoprazole API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Dexlansoprazole API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Dexlansoprazole API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Dexlansoprazole API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Dexlansoprazole API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Dexlansoprazole API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Dexlansoprazole API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Dexlansoprazole API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Dexlansoprazole API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Dexlansoprazole API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Dexlansoprazole API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Piramal Enterprises Limited Corporation Information
Table 115. Piramal Enterprises Limited Description and Major Businesses
Table 116. Piramal Enterprises Limited Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Piramal Enterprises Limited Dexlansoprazole API Product
Table 118. Piramal Enterprises Limited Recent Development
Table 119. Metrochem API Private Limited Corporation Information
Table 120. Metrochem API Private Limited Description and Major Businesses
Table 121. Metrochem API Private Limited Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Metrochem API Private Limited Dexlansoprazole API Product
Table 123. Metrochem API Private Limited Recent Development
Table 124. Zhejiang Hengkang Pharmaceutical Corporation Information
Table 125. Zhejiang Hengkang Pharmaceutical Description and Major Businesses
Table 126. Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Product
Table 128. Zhejiang Hengkang Pharmaceutical Recent Development
Table 129. Lupin Ltd Corporation Information
Table 130. Lupin Ltd Description and Major Businesses
Table 131. Lupin Ltd Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Lupin Ltd Dexlansoprazole API Product
Table 133. Lupin Ltd Recent Development
Table 134. Dipharma Corporation Information
Table 135. Dipharma Description and Major Businesses
Table 136. Dipharma Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Dipharma Dexlansoprazole API Product
Table 138. Dipharma Recent Development
Table 139. Optimus Pharma P Limited Corporation Information
Table 140. Optimus Pharma P Limited Description and Major Businesses
Table 141. Optimus Pharma P Limited Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Optimus Pharma P Limited Dexlansoprazole API Product
Table 143. Optimus Pharma P Limited Recent Development
Table 144. Orchid Chemicals & Pharmaceuticals Corporation Information
Table 145. Orchid Chemicals & Pharmaceuticals Description and Major Businesses
Table 146. Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Product
Table 148. Orchid Chemicals & Pharmaceuticals Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Dexlansoprazole API Distributors List
Table 152. Dexlansoprazole API Customers List
Table 153. Dexlansoprazole API Market Trends
Table 154. Dexlansoprazole API Market Drivers
Table 155. Dexlansoprazole API Market Challenges
Table 156. Dexlansoprazole API Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Dexlansoprazole API Product Picture
Figure 2. Global Dexlansoprazole API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Dexlansoprazole API Market Share by Application in 2020 & 2027
Figure 6. Dexlansoprazole Capsules
Figure 7. Others
Figure 8. Dexlansoprazole API Report Years Considered
Figure 9. Global Dexlansoprazole API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Dexlansoprazole API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Dexlansoprazole API Production Market Share by Region (2016-2021)
Figure 12. Global Dexlansoprazole API Production Market Share by Region (2022-2027)
Figure 13. Dexlansoprazole API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 14. Dexlansoprazole API Production Growth Rate in China (2016-2027) & (Ton)
Figure 15. Dexlansoprazole API Production Growth Rate in China Taiwan (2016-2027) & (Ton)
Figure 16. Dexlansoprazole API Production Growth Rate in India (2016-2027) & (Ton)
Figure 17. Global Dexlansoprazole API Sales 2016-2027 (Ton)
Figure 18. Global Dexlansoprazole API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Dexlansoprazole API Revenue 2016-2027 (US$ Million)
Figure 20. Global Dexlansoprazole API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Dexlansoprazole API Sales Market Share by Region (2016-2021)
Figure 22. Global Dexlansoprazole API Sales Market Share by Region (2022-2027)
Figure 23. North America Dexlansoprazole API Sales YoY (2016-2027) & (Ton)
Figure 24. North America Dexlansoprazole API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Dexlansoprazole API Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Dexlansoprazole API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Dexlansoprazole API Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Dexlansoprazole API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Dexlansoprazole API Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Dexlansoprazole API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Dexlansoprazole API Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Dexlansoprazole API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Dexlansoprazole API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Dexlansoprazole API Revenue in 2020
Figure 35. Dexlansoprazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Dexlansoprazole API Sales Market Share by Type (2016-2027)
Figure 37. Global Dexlansoprazole API Revenue Market Share by Type (2016-2027)
Figure 38. Global Dexlansoprazole API Sales Market Share by Application (2016-2027)
Figure 39. Global Dexlansoprazole API Revenue Market Share by Application (2016-2027)
Figure 40. North America Dexlansoprazole API Sales Market Share by Type (2016-2027)
Figure 41. North America Dexlansoprazole API Revenue Market Share by Type (2016-2027)
Figure 42. North America Dexlansoprazole API Sales Market Share by Application (2016-2027)
Figure 43. North America Dexlansoprazole API Revenue Market Share by Application (2016-2027)
Figure 44. North America Dexlansoprazole API Sales Share by Country (2016-2027)
Figure 45. North America Dexlansoprazole API Revenue Share by Country (2016-2027)
Figure 46. United States Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Dexlansoprazole API Sales Market Share by Type (2016-2027)
Figure 49. Europe Dexlansoprazole API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Dexlansoprazole API Sales Market Share by Application (2016-2027)
Figure 51. Europe Dexlansoprazole API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Dexlansoprazole API Sales Share by Country (2016-2027)
Figure 53. Europe Dexlansoprazole API Revenue Share by Country (2016-2027)
Figure 54. Germany Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 55. France Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Dexlansoprazole API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Dexlansoprazole API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Dexlansoprazole API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Dexlansoprazole API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Dexlansoprazole API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Dexlansoprazole API Revenue Share by Region (2016-2027)
Figure 65. China Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 68. India Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Dexlansoprazole API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Dexlansoprazole API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Dexlansoprazole API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Dexlansoprazole API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Dexlansoprazole API Sales Share by Country (2016-2027)
Figure 79. Latin America Dexlansoprazole API Revenue Share by Country (2016-2027)
Figure 80. Mexico Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Dexlansoprazole API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Dexlansoprazole API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Dexlansoprazole API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Dexlansoprazole API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Dexlansoprazole API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Dexlansoprazole API Revenue Share by Country (2016-2027)
Figure 89. Turkey Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Dexlansoprazole API Revenue (2016-2027) & (US$ Million)
Figure 92. Dexlansoprazole API Value Chain
Figure 93. Dexlansoprazole API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---